ES485221A1 - Un procedimiento para la preparacion de una nueva 3,4-dihi- dro-3-oxoquinoxalina - Google Patents

Un procedimiento para la preparacion de una nueva 3,4-dihi- dro-3-oxoquinoxalina

Info

Publication number
ES485221A1
ES485221A1 ES79485221A ES485221A ES485221A1 ES 485221 A1 ES485221 A1 ES 485221A1 ES 79485221 A ES79485221 A ES 79485221A ES 485221 A ES485221 A ES 485221A ES 485221 A1 ES485221 A1 ES 485221A1
Authority
ES
Spain
Prior art keywords
quinoxalines
ch3o
dihydro
individually
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES79485221A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES485221A1 publication Critical patent/ES485221A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/07Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
    • C07C205/11Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/12Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un procedimiento para la preparación de una nueva 3,4-dihidro- 3-oxoquinoxalina de fórmula I **(Fórmula)** donde R y R4 son individualmente H, NO2 o CH3O; R1 y R2 son individualmente H, NO2, CH3O o halógeno, de manera que por lo menos uno de los radicales R, R1, R2 y R4 es distinto de H, de forma que si ninguno de los radicales R1 o R2 es NO2 o CH3O, R1 y R2 son ambos individualmente halógeno y R y R4 son ambos H y de tal manera que uno de los radicales R1 y R2 es CH3O solamente si uno de los radicales R, R1, R2 o R4 es NO2, con la condición de que solamente uno de los radicales R1 o R2 es cloro; R3 es alquilo C1-C4, cicloalquilo C3-C6, alquenilo C3- C4, H o 2-cloroetilo y n es 0 o 2;
ES79485221A 1978-10-20 1979-10-19 Un procedimiento para la preparacion de una nueva 3,4-dihi- dro-3-oxoquinoxalina Expired ES485221A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95315778A 1978-10-20 1978-10-20
US6044579A 1979-07-25 1979-07-25

Publications (1)

Publication Number Publication Date
ES485221A1 true ES485221A1 (es) 1980-07-01

Family

ID=26739938

Family Applications (2)

Application Number Title Priority Date Filing Date
ES79485221A Expired ES485221A1 (es) 1978-10-20 1979-10-19 Un procedimiento para la preparacion de una nueva 3,4-dihi- dro-3-oxoquinoxalina
ES79485222A Expired ES485222A1 (es) 1978-10-20 1979-10-19 Un procedimiento para la preparacion de una nueva 3,4-dihi- dro-3-oxoquinoxalina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES79485222A Expired ES485222A1 (es) 1978-10-20 1979-10-19 Un procedimiento para la preparacion de una nueva 3,4-dihi- dro-3-oxoquinoxalina

Country Status (19)

Country Link
US (1) US4264600A (es)
EP (1) EP0010426A1 (es)
JP (1) JPS5569514A (es)
AU (1) AU5197779A (es)
BE (1) BE879472A (es)
CA (1) CA1145337A (es)
DD (1) DD146705A5 (es)
DK (1) DK444479A (es)
ES (2) ES485221A1 (es)
FI (1) FI793261A (es)
FR (2) FR2439188A1 (es)
GB (1) GB2034302A (es)
GR (1) GR72941B (es)
IL (1) IL58478A0 (es)
IT (1) IT1193847B (es)
LU (1) LU81798A1 (es)
PH (1) PH15791A (es)
PT (1) PT70340A (es)
RO (1) RO78225A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252954A (en) * 1979-10-25 1981-02-24 Eli Lilly And Company Salts of dihalo-3,4-dihydro-3-oxo-2-quinoxaline carboxylic acids and hindered amines
US4355030A (en) * 1980-11-14 1982-10-19 Eli Lilly And Company Antiviral combinations
JPH0678319B2 (ja) * 1986-03-11 1994-10-05 東ソー株式会社 キノキサリノン誘導体
US5037983A (en) * 1988-05-16 1991-08-06 E. R. Squibb & Sons, Inc. 6,7-dihydroxyquinoxalines as intermediates to beta-lactam antibiotics
US4904775A (en) * 1988-05-16 1990-02-27 E. R. Squibb & Sons, Inc. Heteroaroylhydrazide derivatives of monocyclic beta-lactam antibiotics
CA2024282A1 (en) * 1989-09-21 1991-03-22 Peter H. Ermann Heterocyclic hydrazide derivatives of monocyclic beta-lactam antibiotics
US5169955A (en) * 1990-03-01 1992-12-08 Nippon Kayaku Kabushiki Kaisha Process for producing 2-hydroxyquinoxaline derivatives
ZA918014B (en) * 1990-11-05 1992-07-29 Squibb & Sons Inc Heteroaroyl derivatives of monocyclic beta-lactam antibiotics
WO1992011245A1 (en) * 1990-12-20 1992-07-09 Warner-Lambert Company 2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
TW274550B (es) * 1992-09-26 1996-04-21 Hoechst Ag
AU744540B2 (en) * 1997-09-01 2002-02-28 Kyorin Pharmaceutical Co. Ltd. 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof, and processes for the preparation of both
US8742156B2 (en) 2010-08-14 2014-06-03 British Columbia Cancer Agency Branch Anti-viral carbamimidothioic acid esters
CA2895526C (en) * 2012-12-20 2021-08-24 Qing-bin LU Radiosensitizer compounds for use in combination with radiation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1038505A (en) * 1963-06-04 1966-08-10 Daiichi Seiyaku Co Antileprosy ointment
DE1804328A1 (de) * 1967-10-23 1969-05-22 Donau Pharmazie Gmbh 3-substituierte Chinoxalinone und Verfahren zur Herstellung von 3-substituierten Chinoxalin-2-Onen
GB1215815A (en) 1967-12-20 1970-12-16 Research Corp Production of quinoxaline-di-n-oxides and benzimidazole mono- and di-n-oxides
GB1408675A (en) 1973-03-16 1975-10-01 Allen & Hanburys Ltd Amides derived from quinoxaline
US3654275A (en) * 1969-10-15 1972-04-04 Pfizer & Co C Quinoxalinecarboxamide antiinflammatory agents
GB1308370A (en) 1969-12-09 1973-02-21 Research Corp 1-hydroxy-3-oxo-benzimidazoles quinoxaline-di-n-oxides and benzimidazole-mono-and di-n-oxides
US3962440A (en) * 1973-12-26 1976-06-08 Eli Lilly And Company Quinoxaline compounds as hypnotic agents

Also Published As

Publication number Publication date
IT7926662A0 (it) 1979-10-19
FI793261A (fi) 1980-04-21
JPS5569514A (en) 1980-05-26
PH15791A (en) 1983-03-25
GR72941B (es) 1984-01-16
US4264600A (en) 1981-04-28
FR2439188A1 (fr) 1980-05-16
DD146705A5 (de) 1981-02-25
CA1145337A (en) 1983-04-26
PT70340A (en) 1979-10-01
RO78225A (ro) 1982-02-01
BE879472A (fr) 1980-04-18
GB2034302A (en) 1980-06-04
ES485222A1 (es) 1980-09-01
FR2448899A1 (fr) 1980-09-12
IL58478A0 (en) 1980-01-31
DK444479A (da) 1980-04-21
IT1193847B (it) 1988-08-24
EP0010426A1 (en) 1980-04-30
LU81798A1 (fr) 1980-04-21
AU5197779A (en) 1980-05-01

Similar Documents

Publication Publication Date Title
ES485221A1 (es) Un procedimiento para la preparacion de una nueva 3,4-dihi- dro-3-oxoquinoxalina
NO176101C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-(3-hydroksy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran eller dihydrobenzodioksin)karboksamidderivater
EP1035123A4 (en) NEW HETEROCYCLIC COMPOUNDS
ES2073398T3 (es) Nuevos derivados substituidos del acido bencilideno- y cinamilideno-malonico con actividad como inhibidores de la proliferacion celular.
EP0228845A3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
ES482504A1 (es) Un procedimiento para la preparacion de derivados peptidicos
NO882334D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
HU911782D0 (en) Proces for producing 9-amino-benzodiazepine derivatives
HUT77135A (hu) Eljárás I típusú allergiás betegségek megelőzésére és kezelésére alkalmazható gyógyszerkészítmények előállítására
GB1465025A (en) Substituted phenylisothioureas a process for their preparation and their use as medicaments
ES8303397A1 (es) Un procedimiento para la preparacion de nuevos derivados de quinoleinetanol o quinoleinpropanol utiles como medicamentos
ES8304087A1 (es) "un metodo de preparar derivados de pirazolina".
ES8100249A1 (es) Un metodo para la preparacion de un compuesto de acido hi- droxamico
GB1203430A (en) Heterocyclic spiro compounds
ES8401952A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.
GB1325280A (en) 3-substituted-as-triazino-5,6-c-quinolines
GB1042894A (en) 3-cyanopyrrolidines
HRP930613A2 (en) 4-oxo-azetidine-2-sulphonic acids amides and their salts, process for their production and their use
ES8103774A1 (es) Un procedimiento para preparar nuevos compuestos de triazeno